Company / Book Value per Share
Oruka Therapeutics, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0
FY2024
5-year range
$0 / $4.872
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#189 of 209
Health Care
What the data says
Among 209 Health Care companies, Oruka Therapeutics, Inc. is in the bottom 10% for book value per share. Book Value per Share has declined for 3 consecutive years, from $4.872 in FY2021 to $0 in FY2024.
Based on SEC 10-K filings.
$0 in FY2024 with a 5-year CAGR of -90.5%.
Declined from $3.542 to $0 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -97.7%
- 5-Year CAGR
- -90.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 209This company $0 Sector average $215.686
▼
-100.0% below sector average
Key checks
Key Insights
- Oruka Therapeutics, Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of -90.5%, indicating a declining trend.
- In FY2024, book value per share decreased 100.0% year-over-year.
- Ranks #189 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $2.569 | -27.5% |
| FY2022 | $3.542 | -27.3% |
| FY2021 | $4.872 | +2.1% |
| FY2020 | $4.774 | -38.8% |
| FY2019 | $7.798 | +793.6% |
| FY2018 | $0.873 | -64.3% |
| FY2017 | $2.444 | -41.9% |
| FY2016 | $4.206 | -13.8% |
| FY2015 | $4.879 | +391.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026